# InfuSystem Holdings, Inc: financial statements, quarterly

INFU · NYSE · CIK 1337013 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/infu.md) · [Financials](/companies/infu/financials.md) · [Filings](/companies/infu/filings.md) · [Insiders](/companies/infu/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/infu/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [31.9](/filings/0001628280-24-046739.md) | [31.8 d](/filings/0001628280-25-012095.md) | [32.0](/filings/0001628280-25-023635.md) | [33.7](/filings/0001628280-25-037943.md) | [35.3](/filings/0001628280-25-048869.md) | [33.8 d](/filings/0001628280-26-012804.md) | [34.7](/filings/0001628280-26-032737.md) | [36.0](/filings/0001628280-26-052462.md) | [36.5](/filings/0001628280-25-048869.md) | [36.2 d](/filings/0001628280-26-012804.md) | [33.7](/filings/0001628280-26-032737.md) | [36.9](/filings/0001628280-26-052462.md) |
| Cost of revenue | $m | [16.3](/filings/0001628280-24-046739.md) | [15.1 d](/filings/0001628280-25-012095.md) | [15.5](/filings/0001628280-25-023635.md) | [17.0](/filings/0001628280-25-037943.md) | [16.3](/filings/0001628280-25-048869.md) | [15.6 d](/filings/0001628280-26-012804.md) | [15.5](/filings/0001628280-26-032737.md) | [16.1](/filings/0001628280-26-052462.md) | [15.7](/filings/0001628280-25-048869.md) | [15.8 d](/filings/0001628280-26-012804.md) | [14.0](/filings/0001628280-26-032737.md) | [15.5](/filings/0001628280-26-052462.md) |
| Gross profit | $m | [15.6](/filings/0001628280-24-046739.md) | [16.7 d](/filings/0001628280-25-012095.md) | [16.5](/filings/0001628280-25-023635.md) | [16.7](/filings/0001628280-25-037943.md) | [19.0](/filings/0001628280-25-048869.md) | [18.2 d](/filings/0001628280-26-012804.md) | [19.2](/filings/0001628280-26-032737.md) | [19.9](/filings/0001628280-26-052462.md) | [20.8](/filings/0001628280-25-048869.md) | [20.4 d](/filings/0001628280-26-012804.md) | [19.7](/filings/0001628280-26-032737.md) | [21.4](/filings/0001628280-26-052462.md) |
| Operating income | $m | [1.7](/filings/0001628280-24-046739.md) | [1.3 d](/filings/0001628280-25-012095.md) | [(0.8)](/filings/0001628280-25-023635.md) | [1.9](/filings/0001628280-25-037943.md) | [3.3](/filings/0001628280-25-048869.md) | [2.6 d](/filings/0001628280-26-012804.md) | [0.6](/filings/0001628280-26-032737.md) | [3.8](/filings/0001628280-26-052462.md) | [3.8](/filings/0001628280-25-048869.md) | [3.7 d](/filings/0001628280-26-012804.md) | [1.6](/filings/0001628280-26-032737.md) | [4.2](/filings/0001628280-26-052462.md) |
| Interest expense | $m | [0.6](/filings/0001628280-23-038294.md) | [0.5 d](/filings/0001628280-24-015511.md) | [0.5](/filings/0001628280-24-022249.md) | [0.5](/filings/0001628280-25-037943.md) | [0.5](/filings/0001628280-25-048869.md) | [0.4 d](/filings/0001628280-26-012804.md) | [0.3](/filings/0001628280-26-032737.md) | [0.4](/filings/0001628280-26-052462.md) | [0.3](/filings/0001628280-25-048869.md) | [0.3 d](/filings/0001628280-26-012804.md) | [0.3](/filings/0001628280-26-032737.md) | [0.3](/filings/0001628280-26-052462.md) |
| Income tax | $m | [0.4](/filings/0001628280-24-046739.md) | [0.7 d](/filings/0001628280-25-012095.md) | [(0.2)](/filings/0001628280-25-023635.md) | [0.6](/filings/0001628280-25-037943.md) | [1.0](/filings/0001628280-25-048869.md) | [1.3 d](/filings/0001628280-26-012804.md) | [0.5](/filings/0001628280-26-032737.md) | [0.8](/filings/0001628280-26-052462.md) | [1.2](/filings/0001628280-25-048869.md) | [1.5 d](/filings/0001628280-26-012804.md) | [0.4](/filings/0001628280-26-032737.md) | [0.6](/filings/0001628280-26-052462.md) |
| Net income | $m | [0.7](/filings/0001628280-24-046739.md) | [0.1 d](/filings/0001628280-25-012095.md) | [(1.1)](/filings/0001628280-25-023635.md) | [0.7](/filings/0001628280-25-037943.md) | [1.8](/filings/0001628280-25-048869.md) | [0.9 d](/filings/0001628280-26-012804.md) | [(0.3)](/filings/0001628280-26-032737.md) | [2.6](/filings/0001628280-26-052462.md) | [2.3](/filings/0001628280-25-048869.md) | [2.0 d](/filings/0001628280-26-012804.md) | [1.0](/filings/0001628280-26-032737.md) | [3.2](/filings/0001628280-26-052462.md) |
| Diluted EPS | $ per share | [0.03](/filings/0001628280-24-046739.md) | not reported | [(0.05)](/filings/0001628280-25-023635.md) | [0.03](/filings/0001628280-25-037943.md) | [0.08](/filings/0001628280-25-048869.md) | not reported | [(0.01)](/filings/0001628280-26-032737.md) | [0.12](/filings/0001628280-26-052462.md) | [0.11](/filings/0001628280-25-048869.md) | not reported | [0.05](/filings/0001628280-26-032737.md) | [0.15](/filings/0001628280-26-052462.md) |
| Basic EPS | $ per share | [0.03](/filings/0001628280-24-046739.md) | not reported | [(0.05)](/filings/0001628280-25-023635.md) | [0.03](/filings/0001628280-25-037943.md) | [0.08](/filings/0001628280-25-048869.md) | not reported | [(0.01)](/filings/0001628280-26-032737.md) | [0.12](/filings/0001628280-26-052462.md) | [0.11](/filings/0001628280-25-048869.md) | not reported | [0.05](/filings/0001628280-26-032737.md) | [0.16](/filings/0001628280-26-052462.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.2](/filings/0001628280-23-038294.md) | [0.2](/filings/0001628280-25-012095.md) | [0.8](/filings/0001628280-24-022249.md) | [0.1](/filings/0001628280-24-036502.md) | [0.4](/filings/0001628280-24-046739.md) | [0.5](/filings/0001628280-26-012804.md) | [1.5](/filings/0001628280-25-023635.md) | [0.7](/filings/0001628280-25-037943.md) | [1.0](/filings/0001628280-25-048869.md) | [3.2](/filings/0001628280-26-052462.md) | [2.1](/filings/0001628280-26-032737.md) | [1.0](/filings/0001628280-26-052462.md) |
| Current assets | $m | [29.7](/filings/0001628280-23-038294.md) | [30.6](/filings/0001628280-25-012095.md) | [32.5](/filings/0001628280-24-022249.md) | [32.9](/filings/0001628280-24-036502.md) | [33.6](/filings/0001628280-24-046739.md) | [32.2](/filings/0001628280-26-012804.md) | [35.3](/filings/0001628280-25-023635.md) | [34.8](/filings/0001628280-25-037943.md) | [35.6](/filings/0001628280-25-048869.md) | [36.3](/filings/0001628280-26-052462.md) | [36.7](/filings/0001628280-26-032737.md) | [38.3](/filings/0001628280-26-052462.md) |
| Total assets | $m | [102](/filings/0001628280-24-046739.md) | [103](/filings/0001628280-25-012095.md) | [105](/filings/0001628280-25-023635.md) | [109](/filings/0001628280-25-037943.md) | [105](/filings/0001628280-25-048869.md) | [104](/filings/0001628280-26-012804.md) | [104](/filings/0001628280-26-032737.md) | [101](/filings/0001628280-26-052462.md) | [98.9](/filings/0001628280-25-048869.md) | [101](/filings/0001628280-26-052462.md) | [98.7](/filings/0001628280-26-032737.md) | [97.7](/filings/0001628280-26-052462.md) |
| Current liabilities | $m | [14.3](/filings/0001628280-23-038294.md) | [15.7](/filings/0001628280-25-012095.md) | [17.3](/filings/0001628280-24-022249.md) | [15.9](/filings/0001628280-24-036502.md) | [16.9](/filings/0001628280-24-046739.md) | [17.7](/filings/0001628280-26-012804.md) | [16.0](/filings/0001628280-25-023635.md) | [15.9](/filings/0001628280-25-037943.md) | [18.7](/filings/0001628280-25-048869.md) | [20.2](/filings/0001628280-26-052462.md) | [17.1](/filings/0001628280-26-032737.md) | [15.3](/filings/0001628280-26-052462.md) |
| Total liabilities | $m | [50.6](/filings/0001628280-23-038294.md) | [50.6](/filings/0001628280-25-012095.md) | [52.6](/filings/0001628280-24-022249.md) | [55.0](/filings/0001628280-24-036502.md) | [49.8](/filings/0001628280-24-046739.md) | [46.1](/filings/0001628280-26-012804.md) | [49.1](/filings/0001628280-25-023635.md) | [46.3](/filings/0001628280-25-037943.md) | [43.4](/filings/0001628280-25-048869.md) | [43.2](/filings/0001628280-26-052462.md) | [39.9](/filings/0001628280-26-032737.md) | [38.6](/filings/0001628280-26-052462.md) |
| Long-term debt | $m | [32.7](/filings/0001628280-23-038294.md) | [29.1](/filings/0001628280-25-012095.md) | [29.9](/filings/0001628280-24-022249.md) | [34.2](/filings/0001628280-24-036502.md) | [28.0](/filings/0001628280-24-046739.md) | [23.9](/filings/0001628280-26-012804.md) | [28.7](/filings/0001628280-25-023635.md) | [26.3](/filings/0001628280-25-037943.md) | [20.9](/filings/0001628280-25-048869.md) | [19.6](/filings/0001628280-26-052462.md) | [19.6](/filings/0001628280-26-032737.md) | [20.4](/filings/0001628280-26-052462.md) |
| Current portion of debt | $m | [0.0](/filings/0001628280-23-038294.md) | [0.0](/filings/0001628280-25-012095.md) | [0.0](/filings/0001628280-24-022249.md) | [0.0](/filings/0001628280-24-036502.md) | [0.0](/filings/0001628280-24-046739.md) | [0.0](/filings/0001628280-26-012804.md) | [0.0](/filings/0001628280-25-023635.md) | [0.0](/filings/0001628280-25-037943.md) | [0.0](/filings/0001628280-25-048869.md) | [0.0](/filings/0001628280-26-052462.md) | [0.0](/filings/0001628280-26-032737.md) | [0.0](/filings/0001628280-26-052462.md) |
| Shareholders' equity | $m | [51.5](/filings/0001628280-24-046739.md) | [52.3](/filings/0001628280-26-012804.md) | [52.3](/filings/0001628280-25-037943.md) | [53.5](/filings/0001628280-25-048869.md) | [55.5](/filings/0001628280-25-048869.md) | [57.5](/filings/0001628280-26-052462.md) | [55.1](/filings/0001628280-26-052462.md) | [54.5](/filings/0001628280-26-052462.md) | [55.5](/filings/0001628280-25-048869.md) | [57.3](/filings/0001628280-26-052462.md) | [58.7](/filings/0001628280-26-052462.md) | [59.1](/filings/0001628280-26-052462.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [4,264 d](/filings/0001628280-24-046739.md) | [4,658 d](/filings/0001628280-25-012095.md) | [377](/filings/0001628280-25-023635.md) | [2,309 d](/filings/0001628280-25-037943.md) | [9,842 d](/filings/0001628280-25-048869.md) | [7,931 d](/filings/0001628280-26-012804.md) | [1,780](/filings/0001628280-26-032737.md) | [7,009 d](/filings/0001628280-26-052462.md) | [8,493 d](/filings/0001628280-25-048869.md) | [7,126 d](/filings/0001628280-26-012804.md) | [970](/filings/0001628280-26-032737.md) | [6,777 d](/filings/0001628280-26-052462.md) |
| Capital expenditure | $k | [122 d](/filings/0001628280-24-046739.md) | [408 d](/filings/0001628280-25-012095.md) | [182](/filings/0001628280-25-023635.md) | [337 d](/filings/0001628280-25-037943.md) | [43.0 d](/filings/0001628280-25-048869.md) | [530 d](/filings/0001628280-26-012804.md) | [131](/filings/0001628280-26-032737.md) | [217 d](/filings/0001628280-26-052462.md) | [79.0 d](/filings/0001628280-25-048869.md) | [133 d](/filings/0001628280-26-012804.md) | [157](/filings/0001628280-26-032737.md) | [91.0 d](/filings/0001628280-26-052462.md) |
| Share repurchases | $k | [0.0 d](/filings/0001628280-24-046739.md) | [0.0 d](/filings/0001628280-25-012095.md) | [0.0](/filings/0001628280-25-023635.md) | [283 d](/filings/0001628280-25-037943.md) | [698 d](/filings/0001628280-25-048869.md) | [199 d](/filings/0001628280-26-012804.md) | [2,895](/filings/0001628280-26-032737.md) | [3,500 d](/filings/0001628280-26-052462.md) | [2,168 d](/filings/0001628280-25-048869.md) | [1,306 d](/filings/0001628280-26-012804.md) | [809](/filings/0001628280-26-032737.md) | [3,549 d](/filings/0001628280-26-052462.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [21.5](/filings/0001628280-23-038294.md) | [20.9](/filings/0001628280-24-022249.md) | [21.6](/filings/0001628280-24-036502.md) | [21.7](/filings/0001628280-24-046739.md) | [21.2](/filings/0001628280-25-023635.md) | [21.7](/filings/0001628280-25-037943.md) | [21.7](/filings/0001628280-25-048869.md) | [21.1](/filings/0001628280-26-032737.md) | [21.1](/filings/0001628280-26-052462.md) | [20.9](/filings/0001628280-25-048869.md) | [20.9](/filings/0001628280-26-032737.md) | [20.9](/filings/0001628280-26-052462.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 19,917,181 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001628280-26-052462.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.